Literature DB >> 24597459

Feasibility of creating a National ALS Registry using administrative data in the United States.

Wendy E Kaye1, Marchelle Sanchez, Jennifer Wu.   

Abstract

Uncertainty about the incidence and prevalence of amyotrophic lateral sclerosis (ALS), as well as the role of the environment in the etiology of ALS, supports the need for a surveillance system/registry for this disease. Our aim was to evaluate the feasibility of using existing administrative data to identify cases of ALS. The Agency for Toxic Substances and Disease Registry (ATSDR) funded four pilot projects at tertiary care facilities for ALS, HMOs, and state based organizations. Data from Medicare, Medicaid, the Veterans Health Administration, and Veterans Benefits Administration were matched to data available from site-specific administrative and clinical databases for a five-year time-period (1 January 2001-31 December 2005). Review of information in the medical records by a neurologist was considered the gold standard for determining an ALS case. We developed an algorithm using variables from the administrative data that identified true cases of ALS (verified by a neurologist). Individuals could be categorized into ALS, possible ALS, and not ALS. The best algorithm had sensitivity of 87% and specificity of 85%. We concluded that administrative data can be used to develop a surveillance system/registry for ALS. These methods can be explored for creating surveillance systems for other neurodegenerative diseases.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; epidemiology; prevalence studies; registry

Mesh:

Year:  2014        PMID: 24597459      PMCID: PMC4587982          DOI: 10.3109/21678421.2014.887119

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  35 in total

1.  Sensitivity and positive predictive value of Medicare Part B physician claims for rheumatologic diagnoses and procedures.

Authors:  J N Katz; J Barrett; M H Liang; A M Bacon; H Kaplan; R I Kieval; S M Lindsey; W N Roberts; D M Sheff; R T Spencer; A L Weaver; J A Baron
Journal:  Arthritis Rheum       Date:  1997-09

2.  Inaccuracy of the International Classification of Diseases (ICD-9-CM) in identifying the diagnosis of ischemic cerebrovascular disease.

Authors:  C Benesch; D M Witter; A L Wilder; P W Duncan; G P Samsa; D B Matchar
Journal:  Neurology       Date:  1997-09       Impact factor: 9.910

3.  El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors.

Authors:  B R Brooks
Journal:  J Neurol Sci       Date:  1994-07       Impact factor: 3.181

4.  The sensitivity of Medicare claims data for case ascertainment of six common cancers.

Authors:  G S Cooper; Z Yuan; K C Stange; L K Dennis; S B Amini; A A Rimm
Journal:  Med Care       Date:  1999-05       Impact factor: 2.983

5.  Assessing the accuracy of administrative data in health information systems.

Authors:  John W Peabody; Jeff Luck; Sharad Jain; Dan Bertenthal; Peter Glassman
Journal:  Med Care       Date:  2004-11       Impact factor: 2.983

6.  Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study.

Authors:  G Logroscino; E Beghi; S Zoccolella; R Palagano; A Fraddosio; I L Simone; P Lamberti; V Lepore; L Serlenga
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

7.  Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study.

Authors:  B J Traynor; M B Codd; B Corr; C Forde; E Frost; O Hardiman
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910

Review 8.  Amyotrophic lateral sclerosis is a multifactorial disease.

Authors:  A Eisen
Journal:  Muscle Nerve       Date:  1995-07       Impact factor: 3.217

9.  Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease.

Authors:  R B Forbes; S Colville; G W Cran; R J Swingler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-12       Impact factor: 10.154

Review 10.  Neurodegenerative diseases: an overview of environmental risk factors.

Authors:  Rebecca C Brown; Alan H Lockwood; Babasaheb R Sonawane
Journal:  Environ Health Perspect       Date:  2005-09       Impact factor: 9.031

View more
  13 in total

1.  Use of state administrative data sources to study adolescents and young adults with rare conditions.

Authors:  J A Royer; J W Hardin; S McDermott; L Ouyang; J R Mann; O D Ozturk; J Bolen
Journal:  J Gen Intern Med       Date:  2014-08       Impact factor: 5.128

2.  Opportunities to Improve Palliative Care Delivery in Trauma Critical Illness.

Authors:  Lindsay Haines; Wei Wang; Michael Harhay; Niels Martin; Scott Halpern; Katherine Courtright
Journal:  Am J Hosp Palliat Care       Date:  2021-09-01       Impact factor: 2.090

3.  Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies, 2017.

Authors:  Paul Mehta; Jaime Raymond; Reshma Punjani; Moon Han; Theodore Larson; Wendy Kaye; Lorene M Nelson; Barbara Topol; Oleg Muravov; Corina Genson; D Kevin Horton
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2022-04-15       Impact factor: 3.528

4.  Quantifying a nonnotifiable disease in the United States: the National Amyotrophic Lateral Sclerosis Registry model.

Authors:  D Kevin Horton; Paul Mehta; Vinicius C Antao
Journal:  JAMA       Date:  2014-09-17       Impact factor: 56.272

5.  State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance.

Authors:  Laurie Wagner; Lindsay Rechtman; Heather Jordan; Maggie Ritsick; Marchelle Sanchez; Eric Sorenson; Wendy Kaye
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-09-23       Impact factor: 4.092

6.  Using Administrative Data to Ascertain True Cases of Muscular Dystrophy: Rare Disease Surveillance.

Authors:  Michael G Smith; Julie Royer; Joshua R Mann; Suzanne McDermott
Journal:  JMIR Public Health Surveill       Date:  2017-01-12

7.  Estimation of the Prevalence of Amyotrophic Lateral Sclerosis in the United States Using National Administrative Healthcare Data from 2002 to 2004 and Capture-Recapture Methodology.

Authors:  Lorene M Nelson; Barbara Topol; Wendy Kaye; David Williamson; D Kevin Horton; Paul Mehta; Todd Wagner
Journal:  Neuroepidemiology       Date:  2018-08-09       Impact factor: 3.282

8.  Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009-2011 and survival characteristics through 2015.

Authors:  Reshma Punjani; Laurie Wagner; Kevin Horton; Wendy Kaye
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2019-12-04       Impact factor: 4.092

9.  Evaluating the completeness of the national ALS registry, United States.

Authors:  Wendy E Kaye; Laurie Wagner; Ruoming Wu; Paul Mehta
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-10-11       Impact factor: 4.092

10.  Prevalence of Amyotrophic Lateral Sclerosis - United States, 2014.

Authors:  Paul Mehta; Wendy Kaye; Jaime Raymond; Ruoming Wu; Theodore Larson; Reshma Punjani; Daniel Heller; Jessica Cohen; Tracy Peters; Oleg Muravov; Kevin Horton
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-02-23       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.